Ablation of Argonaute 2 in Schwann cells accelerates the progression of diabetic peripheral neuropathy
Glia · 2023-09 · 71 (9) · 2196-2209
DOI: 10.1002/glia.24387 ↗Kurz gefasst
Fachartikel in der Zeitschrift Glia, online erschienen am 13.05.2023. Verfasst von Baoyan Fan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Henry Ford Health System, Detroit, Michigan, USA. Hauptthemen laut MEDLINE: Diabetic Neuropathies, MicroRNAs, Diabetes Mellitus. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: American Heart Association-American Stroke Association, NIDDK NIH HHS, American Heart Association.
Abstract (Originalsprache)
Schwann cells (SCs) form myelin and provide metabolic support for axons, and are essential for normal nerve function. Identification of key molecules specific to SCs and nerve fibers may provide new therapeutic targets for diabetic peripheral neuropathy (DPN). Argonaute2 (Ago2) is a key molecular player that mediates the activity of miRNA‐guided mRNA cleavage and miRNA stability. Our study found that Ago2 knockout (Ago2‐KO) in proteolipid protein (PLP) lineage SCs in mice resulted in a significant reduction of nerve conduction velocities and impairments of thermal and mechanical sensitivities. Histopathological data revealed that Ago2‐KO significantly induced demyelination and neurodegeneration. When DPN was induced in both wild‐type and Ago2‐KO mice, Ago2‐KO mice exhibited further decreased myelin thickness and exacerbated neurological outcomes compared with wild‐type mice. Deep sequencing analysis of Ago2 immunoprecipitated complexes showed that deregulated miR‐206 in Ago2‐KO mice is highly related to mitochondrial function. In vitro data showed that knockdown of miR‐200 induced mitochondrial dysfunction and apoptosis in SCs. Together, our data suggest that Ago2 in SCs is essential to maintain peripheral nerve function while ablation of Ago2 in SCs exacerbates SC dysfunction and neuronal degeneration in DPN. These findings provide new insight into the molecular mechanisms of DPN.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Henry Ford Health System, Detroit, Michigan, USA.
- Department of Physics, Oakland University, Rochester, Michigan, USA.
- Department of Pathology, Henry Ford Hospital, Detroit, Michigan, USA.
ORCID-Profile: Baoyan Fan, Xian Shuang Liu
Förderung
- American Heart Association-American Stroke Association
- NIDDK NIH HHS
- American Heart Association
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Fan, B., Chopp, M., Zhang, Y., Wang, X., Kemper, A., Zhang, Z. G., & Liu, X. S. (2023). Ablation of Argonaute 2 in Schwann cells accelerates the progression of diabetic peripheral neuropathy. Glia, 71(9), 2196-2209. https://doi.org/10.1002/glia.24387
Vancouver
Fan B, Chopp M, Zhang Y, Wang X, Kemper A, Zhang ZG, et al. Ablation of Argonaute 2 in Schwann cells accelerates the progression of diabetic peripheral neuropathy. Glia. 2023;71(9):2196-2209. doi:10.1002/glia.24387
BibTeX
@article{Fan2023,
author = {Fan, Baoyan and Chopp, Michael and Zhang, Yi and Wang, Xinli and Kemper, Amy and Zhang, Zheng Gang and Liu, Xian Shuang},
title = {Ablation of Argonaute 2 in Schwann cells accelerates the progression of diabetic peripheral neuropathy},
journal = {Glia},
year = {2023},
volume = {71},
number = {9},
pages = {2196--2209},
doi = {10.1002/glia.24387}
}
EUVIMED